phrykt

Outset Medical, Inc. (OM): who owns it and who trades it

As of Nov 16, 2026, OM insiders reported 23 open-market sales worth $369K and 2 purchases worth $870K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Leslie Trigg (CEO), with $122K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Outset Medical

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns OM

92 funds and institutions reported OM shares worth $61.3M at the end of Q2 2026, about 77% of the company. The largest holder is FMR LLC (Fidelity) with 14.8%.

Funds and institutions (13F) 77%Everyone else 23%

10 largest owners, by share of the company

FMR LLC (Fidelity)14.8%
BML Capital Management, LLC13.6%
AQR Capital Management LLC5.4%
Perceptive Advisors LLC4.5%
Vanguard Capital Management LLC4.2%
Assenagon Asset Management S.A.3.7%
Bank of America Corp3.6%
PFM Health Sciences, LP3.1%
Ensign Peak Advisors, Inc2.3%
BlackRock, Inc.2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)2.74M14.80%$11.8MNo change
BML Capital Management, LLC2.52M13.59%$10.9M+32%
AQR Capital Management LLC998,9615.39%$4.3M+24%
Perceptive Advisors LLC833,3334.50%$3.6MNo change
Vanguard Capital Management LLC780,1344.21%$3.4M+2%
Assenagon Asset Management S.A.678,8763.66%$2.9M+35%
Bank of America Corp665,8473.59%$2.9M-30%
PFM Health Sciences, LP582,1223.14%$2.5M-2%
Ensign Peak Advisors, Inc434,3412.34%$1.9M-18%
BlackRock, Inc.418,2112.26%$1.8M-67%
Peapod Lane Capital LLC331,9511.79%$1.4MNew
Marshall Wace, LLP211,9931.14%$916KNew
Geode Capital Management, LLC204,6521.10%$885K-51%
Stratos Wealth Partners, LTD.200,5461.08%$866KNo change
UBS Group AG190,2891.03%$822K-25%
Morgan Stanley181,9830.98%$786K+7%
Millennium Management LLC181,7940.98%$785KNew
Goldman Sachs Group Inc173,4600.94%$749K+86%
Jane Street Group, LLC139,1970.75%$601K+115%
XTX Topco Ltd124,6900.67%$539K-12%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, OM insiders reported $870K of open-market purchases and $369K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$870K
2 trades, 1 people
Sales, 12 months
$369K
23 trades, 5 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Oct 2, 2026
Filed Oct 5, 2026

Purchases and sales by month

$870K$870KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 2, 2026Braden Michael Leonard10% ownerPurchase16,575$3.88$64.2KForm 4
Oct 1, 2026Braden Michael Leonard10% ownerPurchase228,334$3.53$806KForm 4
Aug 17, 2026Leslie TriggCEOSale3,437$4.39$15.1KForm 4
Aug 17, 2026John L. BrottemGeneral CounselSale2,632$4.39$11.6KForm 4
Aug 17, 2026Renee GaetaCFOSale4,543$4.39$19.9KForm 4
Jun 3, 2026Renee GaetaCFOSale17,672$4.94$87.3KForm 4
May 15, 2026Leslie TriggCEOSale3,445$3.70$12.7KForm 4
May 15, 2026Marc NashVice presidentSale1,582$3.70$5.9KForm 4
May 15, 2026John L. BrottemGeneral CounselSale2,638$3.70$9.8KForm 4
Feb 17, 2026John L. BrottemGeneral CounselSale2,842$3.35$9.5KForm 4
Feb 17, 2026Leslie TriggCEOSale3,361$3.35$11.3KForm 4
Feb 17, 2026Marc NashVice presidentSale1,817$3.35$6.1KForm 4
Jan 21, 2026Marc NashVice presidentSale980$4.98$4.9KForm 4
Jan 21, 2026John L. BrottemGeneral CounselSale1,180$5.01$5.9KForm 4
Jan 21, 2026Leslie TriggCEOSale2,120$5.05$10.7KForm 4
Jan 20, 2026Marc NashVice presidentSale5,375$5.12$27.5KForm 4
Jan 20, 2026John L. BrottemGeneral CounselSale9,314$5.12$47.7KForm 4
Jan 20, 2026Leslie TriggCEOSale11,794$5.12$60.4KForm 4
Jan 7, 2026Marc NashVice presidentSale108$4.27$461Form 4
Jan 7, 2026John L. BrottemGeneral CounselSale224$4.27$956Form 4
Jan 7, 2026Leslie TriggCEOSale1,795$4.27$7.7KForm 4
Dec 1, 2025Karen DrexlerDirectorSale1,548$4.37$6.8KForm 4
Nov 17, 2025Leslie TriggCEOSale916$4.60$4.2KForm 4
Nov 17, 2025Marc NashVice presidentSale247$4.60$1.1KForm 4
Nov 17, 2025John L. BrottemGeneral CounselSale388$4.60$1.8KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Braden Michael Leonard10% owner$870K–Oct 2, 2026
Leslie TriggChair and CEO, Director–$122KAug 17, 2026
Renee GaetaChief Financial Officer–$107KAug 17, 2026
John L. BrottemGeneral Counsel–$87.2KAug 17, 2026
Marc NashEVP Operations R&D & Service–$45.9KMay 15, 2026
Karen DrexlerDirector–$6.8KDec 1, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

OM short interest

Low short interest. 4.3% of OM shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went down 60%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 812,767 OM shares were sold short, 4.3% of the shares outstanding, down 12.8% from the report before. At the average daily volume of 94,445 shares, buying them all back would take about 8.6 trading days (days to cover).

Shares short, % of all shares

4.32%May 15Oct 3013.2%

Days to cover

8.6May 15Oct 3014.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026812,7674.32%-13%94,4458.6
Oct 15, 2026932,5594.96%+18%246,1193.8
Sep 30, 2026792,6964.22%-11%133,6575.9
Sep 15, 2026889,5754.73%-1%143,8866.2
Aug 31, 2026901,6824.80%-4%129,0277.0
Aug 14, 2026936,3414.98%-18%156,9136.0
Jul 31, 20261.14M6.16%-6%103,65611.0
Jul 15, 20261.22M6.56%-19%193,7466.3
Jun 30, 20261.49M8.05%-24%456,7983.3
Jun 15, 20261.97M10.63%-11%185,75310.6
May 29, 20262.22M11.99%+8%168,32313.2
May 15, 20262.05M11.08%+2%215,3609.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Outset Medical company events

Outset Medical filed 10 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Aug 28, 2026LeadershipJohn Brottem informed Outset Medical, Inc. of his decision to depart from the Company and his role as General Counsel, effective September 11, 2026, to pursue other professional opportunities. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. Jun 17, 2026AgreementOutset Medical, Inc., entered into the Refresh Amendment to the Purchasing Agreement with HCA Management Services, L.P., dated May 1, 2020, as amended. Filing
  5. Jun 5, 2026VoteReported shareholder vote results. Filing
  6. May 29, 2026LeadershipMarc Nash informed Outset Medical, Inc. of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities. Filing
  7. May 7, 2026ResultsReleased financial results. Filing
  8. Feb 11, 2026ResultsReleased financial results. Filing
  9. Jan 27, 2026AnnouncementOutset Medical, Inc. announced that the U.S. Food and Drug Administration granted 510(k) clearance for its next-generation Tablo platform, which the Company expects to begin shipping to customers in the second quarter of 2026. Filing
  10. Jan 12, 2026LeadershipAndrea Saia, a member of the Company’s Board of Directors, stepped down from the Board, effective January 9, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Outset Medical financials

Famous investors that hold OM

3 of the 50 well-known investors we track reported holding OM in their latest 13F filing. The largest position is Israel Englander's, worth $421K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026140,489$421K0.0%-23%
Jim Simons · Renaissance TechnologiesQ3 202660,628$182K0.0%+40%
Ken Griffin · Citadel AdvisorsQ3 202633,566$101K0.0%+200%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named OM in the last 120 days.

FiledHolderFormStake
Nov 13, 2026AQR Capital Management, LLC13G/A1.8%
Nov 13, 2026AQR Capital Management, LLC13G/A1.8%
Oct 6, 2026BML Investment Partners, L.P.13G/A14.7%
Oct 6, 2026BML Investment Partners, L.P.13G/A14.7%

Questions about Outset Medical, Inc. (OM) stock

Who owns the most OM stock?

The largest reported owner of Outset Medical, Inc. (OM) is FMR LLC (Fidelity), with 14.8% of the company. In total, 92 funds and institutions reported holding OM at the end of Q2 2026, together about 77% of the shares. See the largest owners.

Are OM insiders buying or selling?

In the last 12 months, OM insiders reported 2 open-market purchases worth $870K and 23 sales worth $369K. The latest trade was on Oct 2, 2026. See every trade.

What is the short interest in OM?

As of Oct 30, 2026, 812,767 OM shares were sold short, 4.3% of the shares outstanding, down 12.8% from the report before. At the average daily volume of 94,445 shares, buying them all back would take about 8.6 trading days (days to cover). See the history.

Which famous investors hold OM?

3 of the 50 well-known investors we track reported OM in their latest 13F filing, including Israel Englander, Jim Simons, Ken Griffin. The largest position is worth $421K. See all holders.

Executive pay

Outset Medical's chief executive was paid a total of $3.3M for the year ended Dec 31, 2025, down 19% from $4M the year before. In the last 12 months, Outset Medical's executives and directors bought no stock on the open market and sold $369K.

Chief executive, total pay$3.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$1MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.7MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.